Emerging Nanomedicine


Currently, the treatment of HIV requires regular oral dosage of HIV drugs, and chronic oral dosing has significant complications that arise from the high pill burden experienced by many patients across populations with varying conditions leading to non-adherence to therapies. Recent evaluation of HIV patient groups have shown a willingness to switch to nanomedicine alternatives if benefits can be shown. Research efforts by the Liverpool team have focused on the development of new oral therapies, using Solid Drug Nanoparticle (SDN) technology which can improve drug absorption into the body, reducing both the dose and the cost per dose and enabling existing healthcare budgets to treat more patients.


    Related Conference of Emerging Nanomedicine

    October 16-17, 2023

    34th World Nano Conference

    Vancouver, Canada
    November 08-09, 2023

    4th World Congress on Nanotechnology and Advanced Materials

    Budapest, Hungary
    December 04-05, 2023

    31st International Conference on Nanomedicine and Nanomaterials

    Prague, Czech Republic
    January 11-12, 2024

    2nd Global Summit on Nanoscience and Technology

    Dubai, UAE
    April 11-12, 2024

    41th Global Nanotechnology Congress

    Amsterdam, Netherlands

    Emerging Nanomedicine Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in